Pomalidomide, bortezomib, and dexamethasone vs bortezomib and dexamethasone in relapsed or refractory multiple myeloma (OPTIMISMM): final survival outcomes from a randomized, open-label, phase 3 trial
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Basım Tarihi: 2023
- Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Ankara Üniversitesi Adresli: Evet